Reagents
All reagents and solvents used in the synthesis were purchased from Sigma Aldrich or TCI and used as received. Solvents were stored over molecular sieves 4 Å. and treated with 10 % sodium hydrogencarbonate (5 ml) to quench the HBr. After phase separation and drying over sodium sulfate, dimethylformamide (1 ml) was added to the organic phase and the ether was removed in vacuum.
Caesium carbonate (0.30 g, 0.92 mmol) was added to a solution of 4-aminophthalimide (0.10 g, 0.62 mmol) in dimethylformamide (2 ml) and the mixture was stirred at ambient temperature for 2 h. The 4-bromomethylpyridine in dimethylformamide was added to the suspension and the mixture was stirred for another 18 h. Water (30 ml) and ethyl acetate (30 ml) was added and the resulting phases were separated. The organic phase was washed with brine, dried over sodium sulfate and concentrated in vacuum. The title compound 3, obtained as a yellow solid, could be used for further synthesis without purification (0.12 g, 77 % yield): 
General procedure of the amide coupling
The amine 2 or 3 (0.40 mmol, 1.00 eq.) was dissolved in tetrahydrofurane (5 ml) and purged with argon. The according acid chloride (0.48 mmol, 1.20 eq.) and diisopropylethylamine (0.60 mmol, 1.50 eq.) were added and the resulting mixture was stirred for 2 h at ambient temperature. After removal of the tetrahydrofurane in vacuum, ethyl acetate (20 ml) and 10 % citric acid (20 ml) were added and the resulting phases were separated. The organic phase was washed with 10 % sodium bicarbonate (20 ml) and brine (20 ml), dried over sodium sulfate and concentrated in vacuum. The residue was purified by chromatography on silica gel (Gradient: 0-100 % ethyl acetate in cyclohexane). 
N-(2-benzyl-1,3-dioxoisoindolin-5-yl)-2-phenylacetamide (4)

N-(2-benzyl-1,3-dioxoisoindolin-5-yl)-2-(4-methoxyphenyl)acetamide (5)
Biological Assays
The following assays were ordered from Enzo Life Sciences 
N-(1,3-dioxo-2-(pyridin-4-ylmethyl)isoindolin-5-yl)-2-(4-methoxyphenyl)-acetamide (6)
